Roflumilast and sildenafil in healthy male volunteers: Single-dose pharmacokinetic interactions, safety and tolerability

A. Hünnemeyer, N. Nassr, A. Manegold, R. Fux, G. M. Böhmer, G. Lahu, C. Gleiter (Konstanz, Germany)

Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Session: Drug delivery and pharmacokinetics II
Session type: Thematic Poster Session
Number: 4546
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Hünnemeyer, N. Nassr, A. Manegold, R. Fux, G. M. Böhmer, G. Lahu, C. Gleiter (Konstanz, Germany). Roflumilast and sildenafil in healthy male volunteers: Single-dose pharmacokinetic interactions, safety and tolerability. Eur Respir J 2010; 36: Suppl. 54, 4546

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Safety, pharmacokinetics, and pharmacodynamics of TD-8236, an inhaled pan-JAK inhibitor, following single- and multiple-ascending doses in healthy volunteers and mild asthmatics
Source: Virtual Congress 2021 – Clinical trials in airway diseases: novel treatments and new evidence
Year: 2021



Safety and tolerability of single doses of AZD5069 in healthy volunteers
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Single-dose, first-in-human study of AMG 853: Pharmacokinetics, pharmacodynamics, and safety in healthy adults
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010

Tolerability and pharmacokinetics of inhaled bimosiamose in healthy human volunteers
Source: Eur Respir J 2006; 28: Suppl. 50, 332s
Year: 2006

Single-dose, first-in-human study of AMG 317: safety and pharmacokinetics in healthy and asthmatic adults
Source: Annual Congress 2008 - New treatments for asthma
Year: 2008

Dose escalation study in healthy male subjects to investigate safety, tolerability and systemic exposure of orally inhaled single-doses of AP301
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012


Safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of GSK573719 inhalation powder in healthy subjects
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Evaluation of safety, tolerability, pharmacokinetics, and food effect of Danirixin oral tablets in Japanese elderly healthy subjects
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018




Safety, tolerability and pharmacokinetics of AZD9668, an oral neutrophil elastase inhibitor, in healthy subjects and patients with COPD
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010

Dry powder inhaled ribavirin in healthy volunteers:  safety, tolerability, lung and systemic pharmacokinetics
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017


The safety, tolerability and pharmacokinetics of AZD5069, a novel CXCR2 antagonist, in healthy Japanese volunteers
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012

Safety, tolerability and pharmacokinetics (PK) of AZD8154 (a selective PI3K?d inhibitor) after single ascending inhaled doses in healthy volunteers
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019

Safety and pharmacokinetics of nintedanib plus sildenafil in the INSTAGE trial
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019


Safety, pharmacokinetics and pharmacodynamics of BI 1323495 in healthy males
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020


Multiple-dose study of AMG 317 in adults with asthma: pharmacokinetics and safety
Source: Annual Congress 2008 - New treatments for asthma
Year: 2008

Pulmonary pharmacokinetics and safety of nebulised duramycin in healthy male volunteers
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009


Safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of AZD7594 after single and multiple ascending inhaled doses in healthy Japanese males
Source: International Congress 2017 – COPD management
Year: 2017

Pharmacokinetics and pharmacodynamics of ciclesonide and its active principle after inhalative and intravenous administration in healthy subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 110s
Year: 2002

Safety, tolerability and pharmacokinetics (PK) of repeated doses of GSK573719 inhalation powder, a new long-acting muscarinic antagonist, in healthy adults
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Safety, tolerability and pharmacokinetics of a new inhaled once-daily phosphodiesterase (PDE) 4 inhibitor in healthy volunteers
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013